It has been shown that CCNE2 levels are upregulated in NSCLC tissues, and that miR-30d-5p, by targeting CCNE2, inhibits lung cancer cell proliferation and motility38. The gene discussed is CCNE2; the disease is non-small cell lung carcinoma.